Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website https://jmc.elmerpub.com

Case Report

Volume 17, Number 1, January 2026, pages 21-27


Anesthetic and Transfusion Management in Placenta Accreta Spectrum: Lessons From a Resource-Limited Setting and Mini-Review

Figures

Figure 1.
Figure 1. Ultrasound examination showing placental tissue invading the lower myometrium (arrow).
Figure 2.
Figure 2. Doppler ultrasound examination showing placental tissue invading the myometrium and extending to the serosa. Increased vascular flow was demonstrated on color Doppler ultrasound (arrow).
Figure 3.
Figure 3. Most-Care monitor in intensive care unit.

Tables

Table 1. Complications Associated With PAS
 
CategoryComplications
DIC: disseminated intravascular coagulation; DVT: deep venous thrombosis; ICU: intensive care unit; NICU: neonatal intensive care unit; PAS: placenta accreta spectrum; PE: pulmonary embolism.
HemorrhagicMassive obstetric hemorrhage; transfusion requirement; DIC; hypovolemic shock
SurgicalUrologic injury (bladder, ureter); gastrointestinal injury; vascular injury; nerve injury
PostoperativeInfection (wound, pelvic abscess, sepsis); venous thromboembolism (DVT/PE); wound dehiscence
Reproductive/long-termLoss of fertility (hysterectomy); intra-abdominal adhesions; chronic pelvic pain
Maternal outcomeIncreased morbidity: prolonged ICU stay; increased mortality risk
Neonatal outcomePreterm birth; low birth weight; NICU admission; neonatal mortality

 

Table 2. Anesthetic Management of Massive Bleeding [21-28]
 
StepInterventionDescription
GA: general anesthesia; ICU: intensive care unit; IV: intravenous; RBC: red blood cell; FFP: fresh frozen plasma.
1Monitoring and accessEstablish large-bore IV access (two lines), arterial line, and central venous access if needed. Continuous hemodynamic and urine output monitoring.
2Airway and oxygenationEarly airway control with intubation if patient unstable or anticipated rapid deterioration. Provide 100% oxygen.
3Volume resuscitationStart with balanced crystalloids, transition quickly to blood products. Apply massive transfusion protocol (1:1:1 ratio of RBC/FFP/platelets).
4Hemostatic agentsAdminister tranexamic acid early (within 3 h), consider fibrinogen concentrate or cryoprecipitate if hypofibrinogenemia present.
5Anesthetic techniqueGA in unstable patients; regional may be used in selected stable cases (but be prepared to convert to GA).
6Adjunctive measuresMaintain normothermia, correct acidosis, optimize calcium levels during transfusion, permissive hypotension
7Team communicationClose coordination with obstetricians, blood bank, and ICU team. Activate massive transfusion protocol early.
8Postoperative careTransfer to ICU for ongoing resuscitation, monitoring, and correction of coagulopathy.

 

Table 3. Our Practice to Reduce Massive Bleeding in Obstetrics
 
InterventionDescription
FFP: fresh frozen plasma.
Uterotonics and uterine massageFirst-line measures to stimulate uterine contraction and reduce bleeding.
Tranexamic acidEarly administration (within 3 h) to reduce fibrinolysis and improve survival.
Volume replacementUse crystalloids and initiate massive transfusion protocols (1:1:1 ratio).
Surgical interventionsBalloon tamponade, compression sutures, arterial ligation, or hysterectomy if conservative methods fail.
Correction of coagulopathyAdminister FFP, platelets, cryoprecipitate, or fibrinogen concentrate as indicated.
HemodynamicPermissive hypotension
Multidisciplinary approachClose coordination between obstetric, anesthetic, surgical, and blood bank teams.